Skip to main navigation Skip to search Skip to main content

Churg-Strauss syndrome associated with the leukotriene antagonist montelukast

  • C. Boccagni
  • , F. Tesser
  • , D. Mittino
  • , E. Terazzi
  • , P. Naldi
  • , S. Colombi
  • , E. Zoppis
  • , F. Monaco

Research output: Contribution to journalArticlepeer-review

Abstract

Churg-Strauss syndrome (CSS) is a disseminated small vessel vasculitis characterized by late-onset asthma, upper airways disease, eosinophilia and late neurological manifestations such as peripheral neuropathy. Recently, several cases of CSS have been reported in patients treated with leukotriene antagonists after weaning corticosteroids. We describe a case of CSS developed while the patient was receiving montelukast for asthma treatment, after corticosteroids withdrawal. A causal relationship between montelukast therapy and CSS is hypothesized.

Original languageEnglish
Pages (from-to)21-22
Number of pages2
JournalNeurological Sciences
Volume25
Issue number1
DOIs
Publication statusPublished - Apr 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Churg-Strauss syndrome
  • Montelukast
  • Polyneuropathy
  • Vasculitis

Fingerprint

Dive into the research topics of 'Churg-Strauss syndrome associated with the leukotriene antagonist montelukast'. Together they form a unique fingerprint.

Cite this